ArticleJournal of translational medicine2016

Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling.

Laixi Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.